Related Experiment Videos
Torsades de pointes therapy with phenytoin
1Department of Anesthesiology and Critical Care Medicine, Presbyterian-University Hospital, Pittsburgh, Pennsylvania 15213.
Annals of Emergency Medicine
|February 1, 1991
Summary
Phenytoin effectively treated a patient with life-threatening ventricular arrhythmias, specifically Torsades de Pointes, that resisted standard therapies following myocardial infarction. This highlights phenytoin
Area of Science:
- Cardiology
- Pharmacology
- Electrophysiology
Background:
- Myocardial infarction (MI) can precipitate life-threatening ventricular arrhythmias.
- Torsades de Pointes (TdP) is a specific polymorphic ventricular tachycardia associated with prolonged QT interval, often refractory to standard antiarrhythmic drugs.
Observation:
- A case of a woman experiencing malignant ventricular arrhythmia and TdP post-myocardial infarction is presented.
- The patient's TdP was refractory to conventional therapeutic interventions.
Findings:
- Phenytoin demonstrated significant responsiveness in treating the refractory Torsades de Pointes.
- This suggests phenytoin's potential efficacy as an adjunctive therapy for specific life-threatening ventricular arrhythmias.
Implications:
- Phenytoin may offer a valuable therapeutic option for managing drug-refractory Torsades de Pointes, particularly when conventional treatments fail.
- Further investigation into phenytoin's role in managing complex ventricular arrhythmias is warranted.